GleanMark

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY Trademark

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY is a USPTO trademark filed by Teva Pharmaceutical Industries Limited. Status: Registered.

Trademark Facts

MarkCOPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY
Serial Number87646713
Registration Number5533589
StatusRegistered
Filing Date2017-10-16
Registration Date2018-08-07
Mark TypeCombined
Nice Classes005 (Pharmaceuticals)
OwnerTeva Pharmaceutical Industries Limited
Attorney of RecordLaurence Rickles
Prosecution Events30
Latest EventNA85 on 2024-10-10

Goods & Services

Class 005: Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate

Related